USANA Health Sciences, Inc.
NYQ: USNA📈 ZcoreAI Score
Our AI model analyzes USANA Health Sciences, Inc.'s price action across multiple timeframes using regression channels and statistical scoring.
Get USNA Z-Score →About USANA Health Sciences, Inc.
📊 Fundamental Analysis
USANA Health Sciences, Inc. demonstrates a profit margin of 1.2%, which is below the sector average, suggesting competitive pressure.
The company recently reported 5.9% revenue growth, which is above average for the Consumer Defensive sector.
Return on Equity (ROE) is 2.0%, which suggests room for improvement in capital utilization.
At a current price of $18.11, USNA currently trades near the bottom of its 52-week range (7%), indicating potential value or weakness (Range: $16.60 - $38.32).
💰 Valuation Insight
USNA trades at a 41.9% premium to the sector average PE of 22.00. Analysts expect earnings growth, as indicated by a lower forward PE.